Blog

Find out more about what is happening at Cmed

Looking forward to ASH 2017!
06 Dec

Looking forward to ASH 2017!

06 Dec 2017

The past year in the field of cellular immunotherapy in hematological malignancies has been extremely exciting. We saw FDA approval of the first CAR-T therapy for patients with ALL and then additional approvals for certain types of lymphoma. With several cellular immunotherapy products in development, it is indeed a thrilling time to be involved in the clinical trials of these novel therapies. At the annual American Society of Hematology conference this year, I am looking forward to learning more of recent advances, successes and challenges in developing these therapeutics as we all work together to overcome these hematological diseases that affect so many....

Read post
Cmed to Demonstrate encapsia at Two Leading Oncology Meetings
13 Nov

Cmed to Demonstrate encapsia at Two Leading Oncology Meetings

13 Nov 2017

Cloud-based Clinical Data Suite to be Showcased at Clinical Operations in Oncology Trials Europe and the ASH Annual Meeting Cmed, an oncology focused, innovative technology-led CRO, today announced that it will showcase its encapsia® clinical data suite at two leading oncology meetings, Clinical Operations in Oncology Trials Europe, taking place 5-6 December in Munich, Germany, and the ASH Annual Meeting, taking place 9-12 December in Atlanta, GA. As a full-service CRO, Cmed has a strong reputation in delivering complex and demanding clinical trials across numerous oncology types, including various haematological indications, immuno-oncology, breast, lung, prostate and colorectal....

Read post
Cmed showcasing encapsia at PCT Europe
01 Nov

Cmed showcasing encapsia at PCT Europe

01 Nov 2017

Cmed to Showcase Advanced Data Insights and Analytics Capabilities of encapsia® Clinical Data Suite at Partnerships in Clinical Trials Europe Cmed, an innovative technology-led CRO, will demonstrate its encapsia® clinical data suite at Partnerships in Clinical Trials Europe, taking place 28-29 November 2017 in Amsterdam, The Netherlands. Currently used in trials with nine Pharma companies, including two of the top five, for a variety of electronic data capture (EDC) and direct data capture eSource clinical trials, the solution provides sponsors and their partners with a single point of access for live views of data at any point in a clinical trial....

Read post
Rare diseases - still rare disease, but no longer orphans
13 Oct

Rare diseases - still rare disease, but no longer orphans

13 Oct 2017

Historically, rare diseases were also called orphan diseases. They were orphans because no one was developing therapies for them. There was no chance that a company would be able to recover its investment if it spent time and money developing a treatment for such a small population. Some of these diseases are no longer ‘orphans’ in this regard, because the bio-pharmaceutical industry is now ‘adopting’ them slowly, but steadily. Nonetheless, rarity remains the defining feature of these diseases....

Read post
Love a duck! Cmed win charity race!!
19 Sep

Love a duck! Cmed win charity race!!

19 Sep 2017

The annual Bega duck race in Timisoara, Romania, went off with a splash on Sunday 3rd September, as hundreds of rubber ducks took to the water and went beak-to-beak in some of the most intense racing ever seen across the river Bega. Representing Cmed in the hotly contested “Sponsor Race” was Doctor Duck. Crowds cheered on as ten rubber ducks in a row bobbed down the river in the big race of the day, eagerly awaiting the winner with bated breath....

Read post

Want to learn more?

Please feel free to contact us if you would like to learn more about our skills and experience. We are friendly, open and here to help.

Contact us